Report Detail

Other Global COVID-19 Diagnostic Testing Market Size, Status and Forecast 2020-2026

  • RnM4158537
  • |
  • 25 August, 2020
  • |
  • Global
  • |
  • 134 Pages
  • |
  • QYResearch
  • |
  • Other

COVID-19 Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Nucleic Acid Testing
Antibody Testing

Market segment by Application, split into
Hospitals
Scientific Research

Based on regional and country-level analysis, the COVID-19 Diagnostic Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global COVID-19 Diagnostic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Nucleic Acid Testing
    • 1.2.3 Antibody Testing
  • 1.3 Market by Application
    • 1.3.1 Global COVID-19 Diagnostic Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Scientific Research
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global COVID-19 Diagnostic Testing Market Perspective (2015-2026)
  • 2.2 Global COVID-19 Diagnostic Testing Growth Trends by Regions
    • 2.2.1 COVID-19 Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 COVID-19 Diagnostic Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top COVID-19 Diagnostic Testing Players by Market Size
    • 3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2015-2020)
    • 3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue
  • 3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
    • 3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2019
  • 3.5 Key Players COVID-19 Diagnostic Testing Area Served
  • 3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service
  • 3.7 Date of Enter into COVID-19 Diagnostic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 COVID-19 Diagnostic Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2021-2026)

5 COVID-19 Diagnostic Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America COVID-19 Diagnostic Testing Market Size (2015-2026)
  • 6.2 North America COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
  • 6.3 North America COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
  • 6.4 North America COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe COVID-19 Diagnostic Testing Market Size (2015-2026)
  • 7.2 Europe COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
  • 7.3 Europe COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
  • 7.4 Europe COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China COVID-19 Diagnostic Testing Market Size (2015-2026)
  • 8.2 China COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
  • 8.3 China COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
  • 8.4 China COVID-19 Diagnostic Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan COVID-19 Diagnostic Testing Market Size (2015-2026)
  • 9.2 Japan COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
  • 9.3 Japan COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
  • 9.4 Japan COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia COVID-19 Diagnostic Testing Market Size (2015-2026)
  • 10.2 Southeast Asia COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Cellex
    • 11.1.1 Cellex Company Details
    • 11.1.2 Cellex Business Overview
    • 11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
    • 11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2015-2020))
    • 11.1.5 Cellex Recent Development
  • 11.2 Abbott
    • 11.2.1 Abbott Company Details
    • 11.2.2 Abbott Business Overview
    • 11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
    • 11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.2.5 Abbott Recent Development
  • 11.3 Roche
    • 11.3.1 Roche Company Details
    • 11.3.2 Roche Business Overview
    • 11.3.3 Roche COVID-19 Diagnostic Testing Introduction
    • 11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.3.5 Roche Recent Development
  • 11.4 BioMedomics
    • 11.4.1 BioMedomics Company Details
    • 11.4.2 BioMedomics Business Overview
    • 11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
    • 11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.4.5 BioMedomics Recent Development
  • 11.5 BD
    • 11.5.1 BD Company Details
    • 11.5.2 BD Business Overview
    • 11.5.3 BD COVID-19 Diagnostic Testing Introduction
    • 11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.5.5 BD Recent Development
  • 11.6 Henry Schein
    • 11.6.1 Henry Schein Company Details
    • 11.6.2 Henry Schein Business Overview
    • 11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
    • 11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.6.5 Henry Schein Recent Development
  • 11.7 Safecare Bio-Tech
    • 11.7.1 Safecare Bio-Tech Company Details
    • 11.7.2 Safecare Bio-Tech Business Overview
    • 11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
    • 11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.7.5 Safecare Bio-Tech Recent Development
  • 11.8 Mayo Clinic Laboratories
    • 11.8.1 Mayo Clinic Laboratories Company Details
    • 11.8.2 Mayo Clinic Laboratories Business Overview
    • 11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
    • 11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.8.5 Mayo Clinic Laboratories Recent Development
  • 11.9 Chembio Diagnostics
    • 11.9.1 Chembio Diagnostics Company Details
    • 11.9.2 Chembio Diagnostics Business Overview
    • 11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
    • 11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.9.5 Chembio Diagnostics Recent Development
  • 11.10 Mount Sinai Laboratory
    • 11.10.1 Mount Sinai Laboratory Company Details
    • 11.10.2 Mount Sinai Laboratory Business Overview
    • 11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
    • 11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 11.10.5 Mount Sinai Laboratory Recent Development
  • 11.11 Ortho Clinical Diagnostics
    • 10.11.1 Ortho Clinical Diagnostics Company Details
    • 10.11.2 Ortho Clinical Diagnostics Business Overview
    • 10.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
    • 10.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 10.11.5 Ortho Clinical Diagnostics Recent Development
  • 11.12 Zhejiang Orient Gene Biotech
    • 10.12.1 Zhejiang Orient Gene Biotech Company Details
    • 10.12.2 Zhejiang Orient Gene Biotech Business Overview
    • 10.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
    • 10.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 10.12.5 Zhejiang Orient Gene Biotech Recent Development
  • 11.13 Innovita Biological Technology
    • 10.13.1 Innovita Biological Technology Company Details
    • 10.13.2 Innovita Biological Technology Business Overview
    • 10.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
    • 10.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 10.13.5 Innovita Biological Technology Recent Development
  • 11.14 Guangzhou Wondfo Biotech
    • 10.14.1 Guangzhou Wondfo Biotech Company Details
    • 10.14.2 Guangzhou Wondfo Biotech Business Overview
    • 10.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
    • 10.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 10.14.5 Guangzhou Wondfo Biotech Recent Development
  • 11.15 Guangdong Hecin-Scientific
    • 10.15.1 Guangdong Hecin-Scientific Company Details
    • 10.15.2 Guangdong Hecin-Scientific Business Overview
    • 10.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
    • 10.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 10.15.5 Guangdong Hecin-Scientific Recent Development
  • 11.16 Dynamiker Biotechnology (Tianjin)
    • 10.16.1 Dynamiker Biotechnology (Tianjin) Company Details
    • 10.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
    • 10.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
    • 10.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 10.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
  • 11.17 ADVAITE
    • 10.17.1 ADVAITE Company Details
    • 10.17.2 ADVAITE Business Overview
    • 10.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
    • 10.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
    • 10.17.5 ADVAITE Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Diagnostic Testing. Industry analysis & Market Report on COVID-19 Diagnostic Testing is a syndicated market report, published as Global COVID-19 Diagnostic Testing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Diagnostic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,120.00
    4,680.00
    6,240.00
    3,642.60
    5,463.90
    7,285.20
    615,966.00
    923,949.00
    1,231,932.00
    325,377.00
    488,065.50
    650,754.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report